A new issue of Vaccine is now available: Rotavirus Surveillance, Safety and Economic Data before Vaccine Introduction: a Global Perspective from the World Health Organization Global Rotavirus Surveillance Network 
Edited by Adam L. Cohen, Negar Aliabadi, Fatima Serhan, Jacqueline E. Tate, Patrick Zuber, Umesh D. Parashar This can be accessed from: https://www.sciencedirect.com/journal/vaccine/vol/36/issue/51?dgcid=raven_sd_via_email

Hi all, I just wrote a blog on PATH's DefeatDD.org called "Getting to 'Mars' with immunization delivery," which I thought might be of interest! I really enjoyed the recent blockbuster movie,The Martian. Andas a vaccine advocate supporting PATH's advocacy for stronger immunization supply chains project, I drewa parallel between the coordination, planning, and logistics that it would take for NASA to get humans to Mars (as portrayed in the movie) and the coordination, planning, and logistics that it takes to deliver lifesaving vaccines to every community around the world. If we want to reach our "Mars" of reaching every child, everywhere with vaccines, we need to focus on supply chain workers (or "astronauts"), high-tech cold chain equipment (spaceships), and data for decision-making (control centers). Hope you enjoy. :) -Laura   Laura Edison, MPH Scientific Communications Associate Vaccine Access and Delivery, PATH

The September 2015 Vaccine Information Management System (VIMS)Report on Global Vaccine Introductionfrom IVAC at Johns Hopkins is now availablehere. Recent vaccine introduction updates (since May 2015) include: · Pneumococcal conjugate vaccine (PCV) has been introduced in Eritrea, Guinea-Bissau, Lebanon, Lesotho, and Portugal. · Rotavirus vaccine has been introduced in Kiribati. · Inactivated polio vaccine (IPV) has been introduced in Benin, Bhutan, Cameroon, Central African Republic, Chad, Cote D'Ivoire, Guyana, Kiribati, TFYR Macedonia, Morocco, Niger, Pakistan, Papua New Guinea, Saint Vincent and the Grenadines, Sri Lanka, and Sudan.
Current and archived reports, as well as the PowerPoint slide deck with the latest report graphics, can also be found on the VIMS page of the IVAC website at:http://www.jhsph.edu/ivac/vims/ What is the VIMS Report? The VIMS report displays data and figures on the introduction status of Hib, pneumococcal, rotavirus, and inactivated polio vaccines both globally and in the 73 Gavi countries. The images and text in the report describe: · How many countries have introduced each vaccine or plan to in the future · National levels of vaccine coverage and access, globally and in Gavi countries · Vaccine introduction trends over time · Vaccine introduction status of each of the 194 countries, listed individually

Passing along a great blog post written by Erin Fry Sosne at PATH after taking her son to the clinic for his vaccinations earlier today. Would you go back? Today is my son’s six-month birthday, and my husband and I took him in for his six-month pediatric appointment. He was due for his third and final doses of TDaP, Hib and IPV (pentavalent), HepB, PCV and rotavirus vaccines – only there was no rotavirus vaccine in stock. My state-of-the-art pediatric practice in Washington, DC, had a stock-out. Working on vaccine policy, I hear about stock-outs all of the time. Parents (usually moms) walk for miles and make other sacrifices to bring their babies to health clinics for their vaccines, only to find that the clinic has run out of the vaccine or the order never arrived. For me, this is a mere inconvenience. When the clinic calls that the vaccine is back in stock, I will walk the few blocks with my son, wait a few minutes to see the nurse, and likely show up to work an hour late. For millions of families around the world who aren’t as lucky as my family, the decision to return carries much more weight and burden. - See more at: http://defeatdd.org/blog/would-you-go-back#sthash.H6tELzN4.dpuf